Watchman™ Implant
At the Cottage Heart & Vascular Center, you’ll find cardiovascular services and treatments you would expect to find at a large academic medical center including the latest minimally-invasive procedure options.
Appointments
For appointments at the Cottage Structural Heart Clinic call, 805-324-9012 . In an emergency, call 911 immediately.
Minimally Invasive Procedure
The minimally invasive Watchman procedure seals off the left atrial appendage of the heart, which is a thumb-sized sack, so it no longer can cause problems. Within 45 days of a successful Watchman placement, most patients can stop taking the warfarin blood thinner.
Santa Barbara Cottage Hospital was one of the first hospitals in California to offer the FDA-approved Watchman implant. Cardiologists Dr. Brett Gidney and Dr. Joseph Aragon perform the procedure at Santa Barbara Cottage Hospital.
“Santa Barbara Cottage Hospital has a long history of offering structural heart disease treatment, and that has paved the way for us to offer this new and groundbreaking Watchman procedure for patients,” said Dr. Joseph Aragon, director of the Structural Heart Program and Cardiac Catheterization Lab.
Cardiologists insert the compressed Watchman implant through a vein in the patient’s legs and, with guidance from real-time imaging, thread it through blood vessels to the heart where the implant is expanded to the size of a quarter to close off the left atrial appendage. It takes about 30 minutes to an hour to put the implant in. Patients spend one night in the hospital as a precaution and typically can return to their normal activities the next day.
Minimally Invasive Heart Procedures Help Frank and Cay Celebrate Life
“We wouldn’t be here if not for Cottage and Dr. Joe Aragon,” – Frank and Cay Donohoe, Santa Barbara.
Frank and Cay's Story
About Atrial Fibrillation (AFib)
Atrial fibrillation (AFib) is a heart condition affecting millions of people, in which the upper chambers of the heartbeat too fast and with irregular rhythm. AFib can cause blood to stick together and clot in the heart’s left atrial appendage. If those clots break loose, they can cause a stroke. An estimated 20 percent of all strokes occur in patients with AFib.
The Watchman implant does not cure atrial fibrillation (AFib), and it should not be placed in a patient whose AFib is related to heart valve disease. “The Watchman Implant is for someone with atrial fibrillation who has decided with their doctor, using sound medical reasoning, that blood thinners are not a good long-term option,” said Dr. Gidney.
FDA Approval
Watchman received Food and Drug Administration approval in the United States in 2015 and has been approved in Europe since 2005. It has been implanted in more than 10,000 patients and is approved in more than 70 countries around the world.
